Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-02

FDA Approved: PHENYTOIN SODIUM — Supplemental Application (Acella Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for phenytoin sodium from Acella Pharmaceuticals, LLC, approving a supplemental generic product under the ANDA framework…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTOIN SODIUM (phenytoin sodium)

Snippet

SUPPL AP for PHENYTOIN SODIUM (PHENYTOIN SODIUM)